{"genes":["BRAF","BRAF","EGFR","BRAF","BRAF"],"publicationTypes":["Journal Article"],"abstract":"BRAF inhibitor monotherapy appears to be ineffective in BRAF (V600E)-positive colorectal cancer (CRC) as a result of inherent EGFR-mediated resistance mechanisms. This concept initiated combinatorial treatment approaches. Nevertheless, BRAF inhibition in isogenic CRC cell lines induced enhanced cell-cell adhesion and differentiation, underlining a potential benefit of BRAF inhibitors in CRC. ","title":"BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?","pubmedId":"27308494"}